Revanesse (Cross-linked hyaluronic acid 25 mg/ml) by Prollenium Medical Technologies.
Indications: Correction of moderate to severe facial wrinkles and folds (nasolabial folds).
Administration: Mid to deep dermal injection.
Storage: Store at 2–25 °C, away from direct sunlight. Do not freeze. Single use only.
Medical device (CE-marked). For use by qualified, licensed medical practitioners only.
| Manufacturer | Prollenium Medical Technologies (Canada) |
| Active ingredient | Cross-linked hyaluronic acid 25 mg/ml (Revanesse Versa), with 0.3% lidocaine in the '+' variant. |
| Strength & pack | 2 × 1 ml pre-filled syringes. |
| Form | Sterile injectable gel in pre-filled glass syringe |
| Storage | Store at 2–25 °C, away from direct sunlight. Do not freeze. Single use only. |
| Regulatory status | Medical device (CE-marked). For use by qualified, licensed medical practitioners only. |